Cibotii Rhizoma Extract Mitigates LPS‐Induced Inflammatory Bone Loss by Inhibiting the RANK Signaling Pathway to Suppress Osteoclastogenesis and Bone Resorption
Advanced Biology · 2026-05 · 10 (5)
DOI: 10.1002/adbi.202500599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 03.05.2026. Verfasst von Jin Young Hong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Bone Resorption, Signal Transduction, Osteoclasts, Osteogenesis. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Korea Health Technology R&D Project, Korea Health Industry Development Institute, Ministry of Health and Welfare, Republic of Korea.
Abstract (Originalsprache)
Bone homeostasis is maintained through balanced interactions between osteoblasts and osteoclasts, whereas chronic inflammation disrupts this balance by enhancing osteoclast activity and bone loss. This study investigated the protective effects of Cibotii Rhizoma (CR) on inflammatory bone destruction and its underlying mechanisms. In vitro, CR suppressed receptor activator of nuclear factor kappa B ligand (RANKL)‐induced osteoclastogenesis in bone marrow‐derived monocyte/macrophage (BMM) cultures by downregulating NFATc1, c‐Src, and TRAF6, thereby inhibiting osteoclast formation, podosomal actin ring assembly, and cell fusion. In vivo, administration of CR in an LPS‐induced bone loss mouse model preserved bone microarchitecture, as confirmed by micro‐CT and histological analyses, and significantly reduced osteoclast numbers and calvarial bone erosion. Immunohistochemical staining further revealed decreased RANK and NFATc1 activity in calvarial bone tissue following CR treatment. Collectively, these findings indicate that CR mitigates inflammatory bone loss by targeting RANK signaling to inhibit osteoclastogenesis and bone resorption, highlighting its potential as a therapeutic agent for inflammatory bone diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jaseng Spine and Joint Research Institute, Jaseng Medical Foundation, Seoul, Republic of Korea.
ORCID-Profile: In-Hyuk Ha
Förderung
- Korea Health Technology R&D Project
- Korea Health Industry Development Institute
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Hong, J. Y., Jeon, W. J., Kim, H., Lee, J., Kim, H., Yeo, C., Lee, Y. J., & Ha, I. H. (2026). Cibotii Rhizoma Extract Mitigates LPS‐Induced Inflammatory Bone Loss by Inhibiting the RANK Signaling Pathway to Suppress Osteoclastogenesis and Bone Resorption. Advanced Biology, 10(5). https://doi.org/10.1002/adbi.202500599
Vancouver
Hong JY, Jeon WJ, Kim H, Lee J, Kim H, Yeo C, et al. Cibotii Rhizoma Extract Mitigates LPS‐Induced Inflammatory Bone Loss by Inhibiting the RANK Signaling Pathway to Suppress Osteoclastogenesis and Bone Resorption. Advanced Biology. 2026;10(5). doi:10.1002/adbi.202500599
BibTeX
@article{Hong2026,
author = {Hong, Jin Young and Jeon, Wan-Jin and Kim, Hyunseong and Lee, Junseon and Kim, Hyun and Yeo, Changhwan and Lee, Yoon Jae and Ha, In-Hyuk},
title = {Cibotii Rhizoma Extract Mitigates LPS‐Induced Inflammatory Bone Loss by Inhibiting the RANK Signaling Pathway to Suppress Osteoclastogenesis and Bone Resorption},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {5},
doi = {10.1002/adbi.202500599}
}
EUVIMED